New DOJ Guidance Addresses Drug prescriptions, Price-Gouging, and Antitrust Concerns in the Wake of COVID-19
The U.S. Department of Justice (DOJ) has issued a series of memoranda that discloses the department’s enforcement priorities and provides public guidance related to the ongoing coronavirus crisis. This article explores three key areas of DOJ’s policy: (1) programs that target the improper prescribing or dispensing of drugs that may be effective in treating COVID-19; (2) an initiative to prevent hoarding and price gouging of critical supplies; and (3) antitrust procedures and guidance for collaboration between companies in responding to the crisis. Click here to read more.
Click here for more Dinsmore news.
